Cargando…
A Patient with Genetically Confirmed Myoclonus-Dystonia Responded to Anticholinergic Treatment and Improved Spontaneously
BACKGROUND: The various medical treatments applied to myoclonus-dystonia patients with a mutation of the ε-sarcoglycan gene (SGCE) have not been beneficial in most cases. Most patients experience progressive deterioration or static clinical courses, with only rare cases of spontaneous remission. CAS...
Autores principales: | Lee, Jae Hyeok, Lyoo, Chul Hyoung, Lee, Myung Sik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3259499/ https://www.ncbi.nlm.nih.gov/pubmed/22259621 http://dx.doi.org/10.3988/jcn.2011.7.4.231 |
Ejemplares similares
-
A Case of Myoclonus–Dystonia Responding to Low-frequency Pallidal Stimulation
por: Sarva, Harini, et al.
Publicado: (2017) -
Improvement of Isolated Myoclonus Phenotype in Myoclonus Dystonia after Pallidal Deep Brain Stimulation
por: Ramdhani, Ritesh A., et al.
Publicado: (2016) -
Myoclonus-dystonia syndrome: case report
por: Akarsu, Emel Oguz, et al.
Publicado: (2015) -
Delayed Diagnoses of SGCE Myoclonus-Dystonia
por: Varga, M. Georgeta, et al.
Publicado: (2020) -
Oculogyric Crisis Associated with Disulfiram-Induced Pallidonigral Lesion
por: Lee, Jae Hyeok, et al.
Publicado: (2009)